RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ABEO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Abeona Therapeutics Inc. stock downgraded from Buy Candidate to Sell Candidate after Thursday trading session.
(Updated on Mar 28, 2024)

Sell candidate since Mar 28, 2024 PDF

The Abeona Therapeutics Inc. stock price fell by -1.23% on the last day (Thursday, 28th Mar 2024) from $7.34 to $7.25. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 5.07% from a day low at $7.10 to a day high of $7.46. The price has fallen in 6 of the last 10 days and is down by -10.93% for this period. Volume has increased on the last day by 136 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 267 thousand shares were bought and sold for approximately $1.94 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 59.74% during the next 3 months and, with a 90% probability hold a price between $10.26 and $15.37 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ABEO Signals & Forecast

There are few to no technical positive signals at the moment. The Abeona Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $7.43 and $7.32. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 06, 2024, and so far it has fallen -16.47%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Abeona Therapeutics Inc. stock

Abeona Therapeutics Inc. finds support from accumulated volume at $6.99 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.360 between high and low, or 5.07%. For the last week, the stock has had daily average volatility of 4.83%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ABEO) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Abeona Therapeutics Inc. to open at $7.27, and during the day (based on 14 day Average True Range), to move between $6.66 and $7.84, which gives a possible trading interval of +/-$0.590 (+/-8.14%) up or down from last closing price. If Abeona Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 16.29% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $6.99 (3.59%) than the resistance at $7.53 (3.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Abeona Therapeutics Inc. stock A Buy?

The Abeona Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Abeona Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -3.670 Sell Candidate Downgraded

Predicted Opening Price for Abeona Therapeutics Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$7.27 ( 0.276%) $7.25

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ABEO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 7.63 5.24 %
R2 7.49 3.34 %
R1 7.41 2.17 %
Current price: 7.25
Support S1 7.13 -1.62 %
S2 7.05 -2.79 %
S3 6.91 -4.69 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 7.81 7.72 %
R2 7.57 4.41 %
R1 7.53 3.86 %
Current price 7.25
Support S1 6.99 -3.59%
S2 6.90 -4.83%
S3 6.20 -14.48%

ABEO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 31, 2000 Mar 31, 2000 Mar 31, 2000 $3,706.25 8.55%

FAQ

What is the symbol for Abeona Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Abeona Therapeutics Inc. is ABEO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Abeona Therapeutics Inc. Stock?
The Abeona Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Abeona Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Abeona Therapeutics Inc. Stock?
Abeona Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Abeona Therapeutics Inc. Stock.

What's the current price of Abeona Therapeutics Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Abeona Therapeutics Inc. (ABEO) share was $7.25.

What is the 52-week high and low for Abeona Therapeutics Inc. Stock?
The 52-week high for Abeona Therapeutics Inc. Stock is $9.01 and the 52-week low is $2.65.

What is the market capitalization of Abeona Therapeutics Inc. Stock?
As of the 2024-03-28, the market capitalization of Abeona Therapeutics Inc. is 200.786M.

When is the next earnings date for Abeona Therapeutics Inc.?
The upcoming earnings date for Abeona Therapeutics Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT